NEW YORK (GenomeWeb News) – The National Institute of Allergy and Infectious Diseases plans to fund one contractor to run a lab that will conduct genomics activities to support its Simian Vaccine Evaluation Unit, or SVEU, contract sites and research funded through its Division of Acquired Immune Deficiency Syndrome, or DAIDS.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.